AAAAAA
Results: 1-25/45
Authors:
Xue, ML
Willcox, MDP
Lloyd, A
Wakefield, D
Thakur, A
Citation: Ml. Xue et al., Regulatory role of IL-1 beta in the expression of IL-6 and IL-8 in human corneal epithelial cells during Pseudomonas aeruginosa colonization, CLIN EXP OP, 29(3), 2001, pp. 171-174
Authors:
Thakur, A
Xue, ML
Wang, W
Lloyd, A
Wakefield, D
Willcox, MDP
Citation: A. Thakur et al., Expression of macrophage migration inhibitory factor during Pseudomonas keratitis, CLIN EXP OP, 29(3), 2001, pp. 179-182
Authors:
Busturia, A
Lloyd, A
Bejarano, F
Zavortink, M
Xin, H
Sakonju, S
Citation: A. Busturia et al., The MCP silencer of the Drosophila Abd-B gene requires both Pleiohomeotic and GAGA factor for the maintenance of repression, DEVELOPMENT, 128(11), 2001, pp. 2163-2173
Authors:
Boyette, LW
Lloyd, A
Manuel, S
Boyette, JE
Echt, KV
Citation: Lw. Boyette et al., Development of an exercise expert system for older adults, J REHAB RES, 38(1), 2001, pp. 79-91
Authors:
Angwin, J
Heald, G
Lloyd, A
Howland, K
Davy, M
James, MF
Citation: J. Angwin et al., Reliability and sensitivity of joint space measurements in hand radiographs using computerized image analysis, J RHEUMATOL, 28(8), 2001, pp. 1825-1836
Authors:
Oduntan, G
Rahman, S
Rossdale, P
Carrdus, B
Kendle, A
Lloyd, A
Mingay, A
Sams, V
Badcock, J
Newsham, G
Sammonds, N
Scarpello, F
Citation: G. Oduntan et al., Index Index (Chronicle of censorship from around the globe), INDEX CENS, 30(3), 2001, pp. 96-123
Authors:
Lloyd, A
Hayes, P
Bell, PRF
Naylor, AR
Citation: A. Lloyd et al., The role of risk and benefit perception in informed consent for surgery, MED DECIS M, 21(2), 2001, pp. 141-149
Authors:
Dykes, C
Fox, K
Lloyd, A
Chiulli, M
Morse, E
Demeter, LM
Citation: C. Dykes et al., Impact of clinical reverse transcriptase sequences on the replication capacity of HIV-1 drug-resistant mutants, VIROLOGY, 285(2), 2001, pp. 193-203
Authors:
Wilson, A
Hickie, I
Hadzi-Pavlovic, D
Wakefield, D
Parker, G
Straus, SE
Dale, J
McCluskey, D
Hinds, G
Brickman, A
Goldenberg, D
Demitrack, M
Blakely, T
Wessely, S
Sharpe, M
Lloyd, A
Citation: A. Wilson et al., What is chronic fatigue syndrome? Heterogeneity within an international multicentre study, AUST NZ J P, 35(4), 2001, pp. 520-527
Authors:
Lloyd, A
Citation: A. Lloyd, 5-HT2C-receptor inverse agonists: potential antidepressant/anxiolytic agents, DRUG DISC T, 5(7), 2000, pp. 302-302
Authors:
Lloyd, A
Citation: A. Lloyd, Highly potent in vivo AMPA-receptor antagonists, DRUG DISC T, 5(7), 2000, pp. 302-302
Authors:
Lloyd, A
Citation: A. Lloyd, Potent cRAF1 kinase inhibitors, DRUG DISC T, 5(5), 2000, pp. 210-211
Authors:
Lloyd, A
Citation: A. Lloyd, Integrin alpha(v)beta(3)-receptor antagonists, DRUG DISC T, 5(4), 2000, pp. 165-166
Authors:
Lloyd, A
Citation: A. Lloyd, Novel PDE4 inhibitors, DRUG DISC T, 5(4), 2000, pp. 166-166
Authors:
Lloyd, A
Citation: A. Lloyd, 1,1-dimethylallylcoumarins as nitric oxide generation suppressors, DRUG DISC T, 5(4), 2000, pp. 166-166
Authors:
Lloyd, A
Citation: A. Lloyd, Emerging molecular targets - Exploiting nutraceutical treatments for osteoarthritis and ischaemia, DRUG DISC T, 5(4), 2000, pp. 167-167
Authors:
Lloyd, A
Citation: A. Lloyd, 5-HT1D-receptor antagonists for the treatment of migraine, DRUG DISC T, 5(11), 2000, pp. 530-530
Authors:
Lloyd, A
Citation: A. Lloyd, Endothelin A-receptor antagonists, DRUG DISC T, 5(10), 2000, pp. 479-480
Authors:
Akehurst, R
Anderson, P
Brazier, J
Brennan, A
Briggs, A
Buxton, M
Cairns, J
Calvert, N
Claxton, K
Dixon, S
Fryback, D
Gallivan, S
Green, C
Lloyd, A
McCabe, C
Mitchell, A
Nicholl, J
O'Brien, B
Roberts, J
Sculpher, M
Severens, H
Sullivan, S
Veenstra, D
Citation: R. Akehurst et al., Decision analytic modelling in the economic evaluation of health technologies - A consensus statement, PHARMACOECO, 17(5), 2000, pp. 443-444
Authors:
Brandon, LJ
Boyette, LW
Gaasch, DA
Lloyd, A
Citation: Lj. Brandon et al., Effects of lower extremity strength training on functional mobility in older adults, J AGING P A, 8(3), 2000, pp. 214-227
Authors:
Thomas, C
Rajagopal, A
Windsor, B
Dudler, R
Lloyd, A
Roux, SJ
Citation: C. Thomas et al., A role for ectophosphatase in xenobiotic resistance, PL CELL, 12(4), 2000, pp. 519-533
Authors:
Harris, RJ
Storm, PA
Lloyd, A
Arens, M
Marmion, BP
Citation: Rj. Harris et al., Long-term persistence of Coxiella burnetii in the host after primary Q fever, EPIDEM INFE, 124(3), 2000, pp. 543-549
Authors:
O'Hare, JP
Bilous, R
Mitchell, T
O'Callaghan, CJ
Viberti, GC
Willoughby, R
Riley, J
Robinson, AM
Reckless, JP
Havard, F
Sampson, M
Lloyd, A
Williams, T
Vora, J
Chattington, P
Hampson, K
Ibrahim, H
Borthwick, L
Willoughby, R
Viberti, G
Russell, C
Barnes, D
Macklin, A
Murphy, E
Stephens, E
Vincent, J
Tindall, H
Simpson, H
Knowles, E
Cunningham, B
Simpson, E
Bilous, R
Bilous, M
Mitchell, T
O'Halloran, D
Nugent, S
Hadden, D
Fetherstone, M
McCarton, D
McGurk, C
Johnston, C
Burton, J
Harris, C
Hempstead, H
Baksi, A
Bartlett, J
Heaton, C
Brown, K
Arora, A
Burke, J
Najim, V
Cassar, J
Coppini, D
Chazan, B
Kennedy, R
Smith, J
Flynn, M
Lewis, A
Jeffcoate, W
Peck, G
Pound, N
Large, D
Clarke, M
Llewellyn, H
Ang, H
Davidson, G
McKenna, T
Byrne, P
Fiad, T
Hayes, F
McGra, J
Peters, J
Davies, M
Press, M
Price, D
Jones, L
Wareham, K
Scarpello, J
Hodgson, E
Scott, R
Chaudry, A
Lord, G
Parsons, D
Smyth, C
Tymms, D
Fairhurst, M
White, M
Hepburn, D
Beer, J
Nasir, J
Smith, C
Lenox-Smith, A
Braithwaite, I
Riley, J
Michael, A
Seymour, I
Laffealy, S
Johnson, W
Patel, S
Halls, H
Davall, H
Schyns, C
Citation: Jp. O'Hare et al., Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension results of a randomized controlled trial - Results of a randomized controlled trial, DIABET CARE, 23(12), 2000, pp. 1823-1829
Authors:
Di Girolamo, N
McCluskey, P
Lloyd, A
Coroneo, MT
Wakefield, D
Citation: N. Di Girolamo et al., Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells, INV OPHTH V, 41(3), 2000, pp. 671-679
Authors:
Archer, RH
Dykes, C
Gerondelis, P
Lloyd, A
Fay, P
Reichman, RC
Bambara, RA
Demeter, LM
Citation: Rh. Archer et al., Mutants of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase resistant to nonnucleoside reverse transcriptase inhibitors demonstrate altered rates of RNase H cleavage that correlate with HIV-1 replication fitness in cell culture, J VIROLOGY, 74(18), 2000, pp. 8390-8401